Global (United States, European Union and China) Bowel Management Systems

Bowel Management Systems Comprehensive Study by Type (Irrigation Systems, Nerve Modulation Devices, Colostomy Bags, Others), Application (Hospitals and Ambulatory Surgery Centers, Home Care, Others), Patient Type (Adult, Pediatric) Players and Region - Global Market Outlook to 2027

Bowel Management Systems Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 3.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The bowel management systems help patients to manage their bowel disorders. The bowel disorder in the patients shows symptoms such as incomplete emptying, or chronic constipation, and inability to control bowel movement. The bowel management systems provide containment and diversion of fecal and help to keep the skin clean, dry, and contamination-free. It also retains the moisture that contributes to skin breakdown. The increasing geriatric population across the world is found to be more prone to constipation, diarrhea, and other bowel conditions that help to drive the bowel management systems market in the forecast period. According to AMA Research, the market for Bowel Management Systems is expected to register a CAGR of 3.9% during the forecast period to 2027. This growth is primarily driven by Expanding Target Patient Population and Rapidly Growing Geriatric Population .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitN
Value UnitUSD (Million)
Key Companies in StudyColoplast (Denmark), Medtronic (Ireland), 3M (United States), B. Braun (Germany), C.R. Bard (United States), ConvaTec (United Kingdom), Consure Medical (India), Cogentix Medical (United States), Aquaflush Medical Limited (United Kingdom), Axonics Modulation Technologies (United States) and ConvaTec (United Kingdom)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Technology sector in the Asia Pacific region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Coloplast (Denmark), Medtronic (Ireland), 3M (United States), B. Braun (Germany), C.R. Bard (United States), ConvaTec (United Kingdom), Consure Medical (India), Cogentix Medical (United States), Aquaflush Medical Limited (United Kingdom), Axonics Modulation Technologies (United States) and ConvaTec (United Kingdom) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2022, The FDA has approved Axonics' new, long-lasting, non-rechargeable, sacral nerve modulation (SNM) implantable nerve stimulator. Axonics is a global medical technology company that develops and commercializes innovative technologies to treat bladder and intestinal problems (INS)., In 2018, Coloplast acquired IncoCare, a provider of continence products. This acquisition helped Coloplast expand its presence in Germany. and In 2018, Axonics received marketing approval for its Axonics Sacral Neuromodulation System in Australia
In 2022, Temedica GmbH, a global online health and wellness insight company, today announced that it will be working with Bristol Myers Squibb to develop a digital partner for people with psoriasis. This app helps patients better manage their disease by accompanying them during treatment. Psoriasis is one of the most common chronic inflammatory skin diseases in Germany, affecting approximately 2 million people. There is currently no treatment available. Therefore, patients must rely on a variety of medications to manage their symptoms., In 2021, Coloplast, a global manufacturer of medical devices and an industry leader in intimate healthcare, has entered into a stoma product contract with Vizient, Inc., the nation's leading medical performance improvement company. and In 2018, Coloplast expanded its product portfolio by introducing a new product, SenSura Mio Concave, into its SenSura Mio product line.

Market Drivers
  • Expanding Target Patient Population and Rapidly Growing Geriatric Population
  • Favorable Reimbursement Scenario in Developed Countries

Market Trend
  • Rising Adoption of the AI, Internet of Things, and Big Data Technology

Restraints
  • Discomfort Associated With the Use of Bowel Management Devices
  • Patient Preference for Non-Invasive Clinical Management of Fi

Opportunities
Availability of Technologically Advanced Bowel Management Products
Challenges
Disparities in Reimbursement for Bowel Management Products in Emerging Countries

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Bowel Management Systems Study Sheds Light on
— The Bowel Management Systems Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Bowel Management Systems industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Bowel Management Systems industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Irrigation Systems
  • Nerve Modulation Devices
  • Colostomy Bags
  • Others
By Application
  • Hospitals and Ambulatory Surgery Centers
  • Home Care
  • Others
By Patient Type
  • Adult
  • Pediatric

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Expanding Target Patient Population and Rapidly Growing Geriatric Population
      • 3.2.2. Favorable Reimbursement Scenario in Developed Countries
    • 3.3. Market Challenges
      • 3.3.1. Disparities in Reimbursement for Bowel Management Products in Emerging Countries
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of the AI, Internet of Things, and Big Data Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Bowel Management Systems, by Type, Application, Patient Type and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Bowel Management Systems (Value)
      • 5.2.1. Global Bowel Management Systems by: Type (Value)
        • 5.2.1.1. Irrigation Systems
        • 5.2.1.2. Nerve Modulation Devices
        • 5.2.1.3. Colostomy Bags
        • 5.2.1.4. Others
      • 5.2.2. Global Bowel Management Systems by: Application (Value)
        • 5.2.2.1. Hospitals and Ambulatory Surgery Centers
        • 5.2.2.2. Home Care
        • 5.2.2.3. Others
      • 5.2.3. Global Bowel Management Systems by: Patient Type (Value)
        • 5.2.3.1. Adult
        • 5.2.3.2. Pediatric
      • 5.2.4. Global Bowel Management Systems Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Bowel Management Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Coloplast (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. 3M (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. C.R. Bard (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ConvaTec (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Consure Medical (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cogentix Medical (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aquaflush Medical Limited (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Axonics Modulation Technologies (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. ConvaTec (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Bowel Management Systems Sale, by Type, Application, Patient Type and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Bowel Management Systems (Value)
      • 7.2.1. Global Bowel Management Systems by: Type (Value)
        • 7.2.1.1. Irrigation Systems
        • 7.2.1.2. Nerve Modulation Devices
        • 7.2.1.3. Colostomy Bags
        • 7.2.1.4. Others
      • 7.2.2. Global Bowel Management Systems by: Application (Value)
        • 7.2.2.1. Hospitals and Ambulatory Surgery Centers
        • 7.2.2.2. Home Care
        • 7.2.2.3. Others
      • 7.2.3. Global Bowel Management Systems by: Patient Type (Value)
        • 7.2.3.1. Adult
        • 7.2.3.2. Pediatric
      • 7.2.4. Global Bowel Management Systems Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Bowel Management Systems: by Type(USD Million)
  • Table 2. Bowel Management Systems Irrigation Systems , by Region USD Million (2016-2021)
  • Table 3. Bowel Management Systems Nerve Modulation Devices , by Region USD Million (2016-2021)
  • Table 4. Bowel Management Systems Colostomy Bags , by Region USD Million (2016-2021)
  • Table 5. Bowel Management Systems Others , by Region USD Million (2016-2021)
  • Table 6. Bowel Management Systems: by Application(USD Million)
  • Table 7. Bowel Management Systems Hospitals and Ambulatory Surgery Centers , by Region USD Million (2016-2021)
  • Table 8. Bowel Management Systems Home Care , by Region USD Million (2016-2021)
  • Table 9. Bowel Management Systems Others , by Region USD Million (2016-2021)
  • Table 10. Bowel Management Systems: by Patient Type(USD Million)
  • Table 11. Bowel Management Systems Adult , by Region USD Million (2016-2021)
  • Table 12. Bowel Management Systems Pediatric , by Region USD Million (2016-2021)
  • Table 13. South America Bowel Management Systems, by Country USD Million (2016-2021)
  • Table 14. South America Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 15. South America Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 16. South America Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 17. Brazil Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 18. Brazil Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 19. Brazil Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 20. Argentina Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 21. Argentina Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 22. Argentina Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 23. Rest of South America Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 24. Rest of South America Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 25. Rest of South America Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 26. Asia Pacific Bowel Management Systems, by Country USD Million (2016-2021)
  • Table 27. Asia Pacific Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 28. Asia Pacific Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 29. Asia Pacific Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 30. China Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 31. China Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 32. China Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 33. Japan Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 34. Japan Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 35. Japan Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 36. India Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 37. India Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 38. India Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 39. South Korea Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 40. South Korea Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 41. South Korea Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 42. Taiwan Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 43. Taiwan Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 44. Taiwan Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 45. Australia Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 46. Australia Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 47. Australia Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 48. Rest of Asia-Pacific Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 51. Europe Bowel Management Systems, by Country USD Million (2016-2021)
  • Table 52. Europe Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 53. Europe Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 54. Europe Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 55. Germany Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 56. Germany Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 57. Germany Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 58. France Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 59. France Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 60. France Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 61. Italy Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 62. Italy Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 63. Italy Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 64. United Kingdom Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 65. United Kingdom Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 66. United Kingdom Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 67. Netherlands Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 68. Netherlands Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 69. Netherlands Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 70. Rest of Europe Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 71. Rest of Europe Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 72. Rest of Europe Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 73. MEA Bowel Management Systems, by Country USD Million (2016-2021)
  • Table 74. MEA Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 75. MEA Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 76. MEA Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 77. Middle East Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 78. Middle East Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 79. Middle East Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 80. Africa Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 81. Africa Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 82. Africa Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 83. North America Bowel Management Systems, by Country USD Million (2016-2021)
  • Table 84. North America Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 85. North America Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 86. North America Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 87. United States Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 88. United States Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 89. United States Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 90. Canada Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 91. Canada Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 92. Canada Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 93. Mexico Bowel Management Systems, by Type USD Million (2016-2021)
  • Table 94. Mexico Bowel Management Systems, by Application USD Million (2016-2021)
  • Table 95. Mexico Bowel Management Systems, by Patient Type USD Million (2016-2021)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Bowel Management Systems: by Type(USD Million)
  • Table 108. Bowel Management Systems Irrigation Systems , by Region USD Million (2022-2027)
  • Table 109. Bowel Management Systems Nerve Modulation Devices , by Region USD Million (2022-2027)
  • Table 110. Bowel Management Systems Colostomy Bags , by Region USD Million (2022-2027)
  • Table 111. Bowel Management Systems Others , by Region USD Million (2022-2027)
  • Table 112. Bowel Management Systems: by Application(USD Million)
  • Table 113. Bowel Management Systems Hospitals and Ambulatory Surgery Centers , by Region USD Million (2022-2027)
  • Table 114. Bowel Management Systems Home Care , by Region USD Million (2022-2027)
  • Table 115. Bowel Management Systems Others , by Region USD Million (2022-2027)
  • Table 116. Bowel Management Systems: by Patient Type(USD Million)
  • Table 117. Bowel Management Systems Adult , by Region USD Million (2022-2027)
  • Table 118. Bowel Management Systems Pediatric , by Region USD Million (2022-2027)
  • Table 119. South America Bowel Management Systems, by Country USD Million (2022-2027)
  • Table 120. South America Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 121. South America Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 122. South America Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 123. Brazil Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 124. Brazil Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 125. Brazil Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 126. Argentina Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 127. Argentina Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 128. Argentina Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 129. Rest of South America Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 130. Rest of South America Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 131. Rest of South America Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 132. Asia Pacific Bowel Management Systems, by Country USD Million (2022-2027)
  • Table 133. Asia Pacific Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 134. Asia Pacific Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 135. Asia Pacific Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 136. China Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 137. China Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 138. China Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 139. Japan Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 140. Japan Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 141. Japan Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 142. India Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 143. India Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 144. India Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 145. South Korea Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 146. South Korea Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 147. South Korea Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 148. Taiwan Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 149. Taiwan Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 150. Taiwan Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 151. Australia Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 152. Australia Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 153. Australia Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 154. Rest of Asia-Pacific Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 155. Rest of Asia-Pacific Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 156. Rest of Asia-Pacific Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 157. Europe Bowel Management Systems, by Country USD Million (2022-2027)
  • Table 158. Europe Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 159. Europe Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 160. Europe Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 161. Germany Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 162. Germany Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 163. Germany Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 164. France Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 165. France Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 166. France Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 167. Italy Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 168. Italy Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 169. Italy Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 170. United Kingdom Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 171. United Kingdom Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 172. United Kingdom Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 173. Netherlands Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 174. Netherlands Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 175. Netherlands Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 176. Rest of Europe Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 177. Rest of Europe Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 178. Rest of Europe Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 179. MEA Bowel Management Systems, by Country USD Million (2022-2027)
  • Table 180. MEA Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 181. MEA Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 182. MEA Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 183. Middle East Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 184. Middle East Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 185. Middle East Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 186. Africa Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 187. Africa Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 188. Africa Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 189. North America Bowel Management Systems, by Country USD Million (2022-2027)
  • Table 190. North America Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 191. North America Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 192. North America Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 193. United States Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 194. United States Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 195. United States Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 196. Canada Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 197. Canada Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 198. Canada Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 199. Mexico Bowel Management Systems, by Type USD Million (2022-2027)
  • Table 200. Mexico Bowel Management Systems, by Application USD Million (2022-2027)
  • Table 201. Mexico Bowel Management Systems, by Patient Type USD Million (2022-2027)
  • Table 202. Research Programs/Design for This Report
  • Table 203. Key Data Information from Secondary Sources
  • Table 204. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Bowel Management Systems: by Type USD Million (2016-2021)
  • Figure 5. Global Bowel Management Systems: by Application USD Million (2016-2021)
  • Figure 6. Global Bowel Management Systems: by Patient Type USD Million (2016-2021)
  • Figure 7. South America Bowel Management Systems Share (%), by Country
  • Figure 8. Asia Pacific Bowel Management Systems Share (%), by Country
  • Figure 9. Europe Bowel Management Systems Share (%), by Country
  • Figure 10. MEA Bowel Management Systems Share (%), by Country
  • Figure 11. North America Bowel Management Systems Share (%), by Country
  • Figure 12. Global Bowel Management Systems share by Players 2021 (%)
  • Figure 13. Global Bowel Management Systems share by Players (Top 3) 2021(%)
  • Figure 14. Global Bowel Management Systems share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Coloplast (Denmark) Revenue, Net Income and Gross profit
  • Figure 17. Coloplast (Denmark) Revenue: by Geography 2021
  • Figure 18. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 19. Medtronic (Ireland) Revenue: by Geography 2021
  • Figure 20. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 21. 3M (United States) Revenue: by Geography 2021
  • Figure 22. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 23. B. Braun (Germany) Revenue: by Geography 2021
  • Figure 24. C.R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 25. C.R. Bard (United States) Revenue: by Geography 2021
  • Figure 26. ConvaTec (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. ConvaTec (United Kingdom) Revenue: by Geography 2021
  • Figure 28. Consure Medical (India) Revenue, Net Income and Gross profit
  • Figure 29. Consure Medical (India) Revenue: by Geography 2021
  • Figure 30. Cogentix Medical (United States) Revenue, Net Income and Gross profit
  • Figure 31. Cogentix Medical (United States) Revenue: by Geography 2021
  • Figure 32. Aquaflush Medical Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. Aquaflush Medical Limited (United Kingdom) Revenue: by Geography 2021
  • Figure 34. Axonics Modulation Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 35. Axonics Modulation Technologies (United States) Revenue: by Geography 2021
  • Figure 36. ConvaTec (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 37. ConvaTec (United Kingdom) Revenue: by Geography 2021
  • Figure 38. Global Bowel Management Systems: by Type USD Million (2022-2027)
  • Figure 39. Global Bowel Management Systems: by Application USD Million (2022-2027)
  • Figure 40. Global Bowel Management Systems: by Patient Type USD Million (2022-2027)
  • Figure 41. South America Bowel Management Systems Share (%), by Country
  • Figure 42. Asia Pacific Bowel Management Systems Share (%), by Country
  • Figure 43. Europe Bowel Management Systems Share (%), by Country
  • Figure 44. MEA Bowel Management Systems Share (%), by Country
  • Figure 45. North America Bowel Management Systems Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Coloplast (Denmark)
  • Medtronic (Ireland)
  • 3M (United States)
  • B. Braun (Germany)
  • C.R. Bard (United States)
  • ConvaTec (United Kingdom)
  • Consure Medical (India)
  • Cogentix Medical (United States)
  • Aquaflush Medical Limited (United Kingdom)
  • Axonics Modulation Technologies (United States)
  • ConvaTec (United Kingdom)
Additional players considered in the study are as follows:
Hollister (United States) , MBH-International A/S (Denmark) , Mederi Therapeutics Inc. (United States) , Welland Medical Limited (United Kingdom) , Wellspect HealthCare (Sweden)
Select User Access Type

Key Highlights of Report


Jul 2022 166 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Bowel Management Systems Quantitative research analysis
Global (United States, European Union and China) Bowel Management Systems Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Bowel Management Systems Market are Coloplast (Denmark), Medtronic (Ireland), 3M (United States), B. Braun (Germany), C.R. Bard (United States), ConvaTec (United Kingdom), Consure Medical (India), Cogentix Medical (United States), Aquaflush Medical Limited (United Kingdom), Axonics Modulation Technologies (United States) and ConvaTec (United Kingdom) etc.
Hospitals and Ambulatory Surgery Centers segment in Global market to hold robust market share owing to "Expanding Target Patient Population and Rapidly Growing Geriatric Population ".
AMA Research predicts that European and United States Players will contribute to the maximum growth of Global Bowel Management Systems market throughout the forecasted period.

Know More About Global (United States, European Union and China) Bowel Management Systems Report?

Have a Query? Click Here

Other Related Reports

Cardiac Valve Repair Comprehensive Study by Type (Trans-Catheter Heart Valve, Tissue Heart Valve, Mechanical Heart Valve, Others), Disease (Aortic Valve Replacement, Mitral Valve Stenosis, Heart Va...
$ 3450
eClinical Solutions Comprehensive Study by Type (Web-hosted (On-demand), Licensed Enterprise (On-premise), Cloud-based (SaaS)), Application (Pharmaceutical and Biopharmaceutical Companies, Contract R...
$ 3450
Healthcare Mobility Solutions Comprehensive Study by Type (Mobile Devices, Mobile Apps, Enterprise Platforms), Application (Enterprise Solutions (Patient Care Management, Operations Management, Workf...
$ 3750
Cardiac Pacing Comprehensive Study by Type (Temporary, Single-Chamber, Dual-Chamber, Single-Chamber ICD, Dual-Chamber ICD), Application (Bradycardia, Atrial fibrillation, Heart failure, Syncope), End...
$ 3450
Stroke Management Comprehensive Study by Type (Ischemic, Hemorrhagic, Transient Ischemic Attack (TIA))), Application (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers), Diagnostics (Magnetic...
$ 3750
Hybrid Operating Room Technology Comprehensive Study by Type (Intraoperative Diagnostic imaging systems (Angiography systems, MRI systems, CT systems, Other), Operating room fixtures (Operating table...
$ 3750